Clinical Trial Update: Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

View source ↗

Summary

This study reports real-world clinical, neurological, tolerability, and safety outcomes for Tecfidera (dimethyl fumarate) and Rebif (interferon beta-1a) in rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)
• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: IMS HEALTH GmbH & Co. OHG | Conditions: Relapsing-remitting Multiple Sclerosis | Status: COMPLETED